:: CLD COMMUNICATIONS ::


	12-13-2007		Merck recalls 1.2 mln doses of children's vaccines

	11-19-2007		Bayer's Nexavar gets U.S. FDA nod for liver cancer

	10-04-2007		Canada pulls Prexige on hepatitis fears

	09-21-2007		EU agency backs Bayer's Nexavar for liver cancer

	08-13-2007		Australia bans Novartis's Prexige on liver worries

	04-06-2007		US FDA clears Cangene's anti-hepatitis B product

	03-07-2007		REFILE: Baraclude treatment of HBV may induce HIV resistance

	03-01-2007		Baraclude treatment of HBV may induce HIV resistance

	09-26-2006		WHO approves new child vaccine

	06-28-2006		European Commission approves Baraclude for chronic hepatitis B

	04-28-2006		BMS' Baraclude and Sanofi Pasteur MSD's RotaTeq set for EU approval

	02-22-2006		Britain's NICE backs Roche's Pegasys and Gilead's Hepsera for hepatitis B

	02-07-2006		Canada: may be tie between Sanofi's Ketek, liver harm

	01-10-2006		J&J recalls some hepatitis blood tests

	10-05-2005		EU OKs briefer Schering-Plough hepatitis C therapy

	08-15-2005		FDA approves use of Merck hepatitis A vaccine in 1-year-olds

	05-16-2005		Roche gets FDA approval for Pegasys in hepatitis B

	03-30-2005		US FDA clears Bristol-Myers new drug for chronic hepatitis B

	03-30-2005		Bayer gets FDA nod for hepatitis A blood test

	03-16-2005		US FDA, Biogen warn over multiple sclerosis drug

	03-11-2005		Bristol-Myers hepatitis drug impressive - US panel

	03-10-2005		Entecavir effective against hepatitis B

	02-03-2005		Roche's Pegasys wins EU approval for HIV patients

	02-03-2005		Lilly's Strattera may be associated with liver problems - UK agency

	01-19-2005		US FDA warns about risks of Boehringer AIDS drug

	01-18-2005		Bayer gets US FDA approval for hepatitis C test